Nomogram Based on Preoperative Fibrinogen and Systemic Immune-Inflammation Index Predicting Recurrence and Prognosis of Patients with Borrmann Type III Advanced Gastric Cancer
DOI: https://doi.org/10.2147/JIR.S404585
IF: 4.5
2023-03-12
Journal of Inflammation Research
Abstract:Hao Wang, 1, &ast Xin Yin, 1, &ast Keru Ma, 2, &ast Yufei Wang, 1, &ast Tianyi Fang, 1 Yao Zhang, 1 Yingwei Xue 1 1 Department of Gastroenterological Surgery, Harbin Medical University Cancer Hospital, Harbin, People's Republic of China; 2 Department of Thoracic Surgery, Esophagus and Mediastinum, Harbin Medical University Cancer Hospital, Harbin, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yingwei Xue, Department of Gastrointestinal Surgery, Harbin Medical University Cancer Hospital, Harbin Medical University, Harbin, 150081, People's Republic of China, Tel +86-13304646901, Email Background and Objectives: The prognosis is known to differ significantly among advanced gastric cancer (AGC) with Borrmann type III. This study aimed to evaluate the prognosis of these patients more individually. Methods: We selected 542 AGC patients with Borrmann type III. We used the receiver operating characteristic curve to analyze the cutoff values of inflammation indexes, and used Kaplan–Meier and Log rank tests to analyze recurrence-free survival (RFS) and overall survival (OS). The independent risk factors for recurrence and prognosis were analyzed by Cox proportional hazards regression model. The nomogram models were constructed by R studio. Results: Patients with high preoperative fibrinogen (F) and systemic immune-inflammation index (SII) levels had worse RFS and OS and higher risk of postoperative locoregional recurrence, hematogenous metastasis and lymph node metastasis. F and SII can combine with different clinicopathological features (all P < 0.05) to construct nomograms to predict 5-year recurrence and prognosis, which both were superior to pTNM stage alone. Conclusion: The nomogram models based on F and SII can evaluate AGC with Borrmann type III postoperative recurrence and prognosis. Keywords: gastric cancer, Borrmann classification, fibrinogen, systemic immune-inflammation index, recurrence, nomogram Gastric cancer (GC) is the third malignant tumor that causes cancer death, with about 865,000 deaths annually. 1 There were of 60% early GC patients in Korea and Japan, while more than 80% advanced GC (AGC) in China. 2,3 In order to evaluate the AGC patients prognosis, experts have proposed a variety of classification methods according to tumor biological characteristics. 4,5 Since 1926, the Borrmann classification according to tumor macroscopic characteristics, 6 and the most common macro type of AGC is Borrmann III, 7,8 which has significant prognostic differences according to different clinicopathological features. Hosoda et al 9 considered that tumor size was related to the prognosis of AGC with Borrmann III. The five -year survival rate of patients with preoperative tumor diameter ≥10 cm was lower than those with tumor size <10 cm (27.9% vs 49.9%). Zhai et al 10 found that the presence or absence of vascular infiltration had a significant impact on the survival of AGC with Borrmann type III (16.4% vs 29.1%). Therefore, combining the clinicopathological features to build prognostic models to evaluate prognosis of AGC patients with Borrmann III will contribute to individualized treatment. Tumor immunity plays a crucial role in immunotherapy, because clinical experts can select the specific immune trigger point. 11 Galon proposed the pTNM-I (Immunology) stage, which suggests that the tumor immunity can provide comprehensive prognosis information. 12,13 However, the selection of tissue section sites limits immunohistochemical staining. Then, peripheral blood immune also plays an important role in the occurrence of tumors and progress. Fibrinogen (F) plays an important role in the coagulation process and inflammatory response, and elevated levels suggest a poor prognosis in patients with GC. 14 Our research team found that for early diagnosis of GC, the predicted performance of neutrophil–lymphocyte ratio (NLR) and platelet–lymphocyte ratio (PLR) were significantly better than traditional tumor markers. 15 Furthermore, there are significant differences in the peripheral immune status of patients with different Lauren type patients. 16 Borrmann type III AGC as an infiltrative ulcerative carcinoma usually has a large ulcer surface, and may be associated with a stronger inflammatory response. 17,18 However, there is no research to analyze its relationship with the peripheral immune inflammatory response. Thus, whether peripheral inflammation indexes and clinicopathological features ca -Abstract Truncated-
immunology